| Patent # | Description |
|---|---|
| US-4,833,174 |
Wood-like polymeric composition The labor costs associated with manufacturing wooden articles often represent a substantial portion of the total cost of producing the wooden article. This... |
| US-4,833,173 |
Coagulated materials The invention relates to a coagulable composition, to a process for the preparation of a coagulated material by impregnating a textile cloth in an impregnating... |
| US-4,833,172 |
Stretched microporous material Precursor microporous material comprising a matrix consisting essentially of linear ultrahigh molecular weight polyolefin, a large proportion of finely divided... |
| US-4,833,171 |
Synthesis gas system Method and apparatus for the production of synthesis gas from hydrocarbonaceous gases, wherein a hydrocarbonaceous gas is preheated, reacted with oxygen in the... |
| US-4,833,170 |
Process and apparatus for the production of heavier hydrocarbons from
gaseous light hydrocarbons A process and apparatus for the production of heavier hydrocarbons from one or more gaseous light hydrocarbons is provided. The process comprises reacting the... |
| US-4,833,169 |
Hydropyridine derivatives Hydropyridine derivatives of the formula ##STR1## in which R.sub.1 represents carboxy, lower alkoxycarbonyl, carbamoyl, N-lower alkylcarbamoyl or... |
| US-4,833,168 |
Avermectin reformatsky adducts There are disclosed novel avermectin compounds wherein the glycosyl side chain is substituted with, or replaced by an alkyl ester group in a Reformatsky... |
| US-4,833,167 |
2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids Disclosed are 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids I, where the generic 2-aza group includes azido, acylamino, amino, alkylamino,... |
| US-4,833,166 |
Growth hormone releasing hormone complementary peptides The present invention provides synthetic peptides and fragments and analogs thereof complementary to growth hormone releasing hormone, and antibodies raised... |
| US-4,833,165 |
Method of inactivating HTLV-III virus in blood HTLV-III virus in blood or blood components is inactivated by treatment with about 0.1-5% of phenol, formaldehyde, or mixtures thereof, at a temperature of about... |
| US-4,833,164 |
2-substituted-1-naphthols, pharmaceutical compositions of, and their use
as 5-lipoxygenase inhibitors 2-Substituted-1-naphthols are 5-lipoxygenase inhibitors which make them useful in the treatment of inflammation, obstructive lung diseases and/or psoriasis.... |
| US-4,833,163 |
Novel cyclopropane carboxylic acid derivatives Novel isomers and mixtures thereof of cyclopropane carboxylic acid derivatives with a 3-unsaturated side chain of Z geometry of the formula ##STR1## wherein... |
| US-4,833,162 |
Substituted benzeneacetonitriles and their use as calcium channel
blockers This invention relates to novel A-[[2-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]ethyl]thio]-3,4-dimethoxy -A-substituted benzeneacetonitrile compounds and a... |
| US-4,833,161 |
Carboxylic acid derivatives and pharmaceutical compositions and uses The present invention provides carboxylic acid derivatives of the general formula: ##STR1## wherein R.sub.1 and R.sub.2, which can be the same or different,... |
| US-4,833,160 |
3-(3,5-di-tert-butyl-4-hydroxy benzylidene)-2-pyrrolidone and
substituted derivatives thereof 3-(3,5-di-tert-butyl-4-hydroxy-benzylidene)-2-pyrrolidone and N-substituted derivatives thereof are described. The substituent includes alkyl, alkoxy, alkynyl... |
| US-4,833,159 |
Insecticidal azolyl propanols Fungicidal and insecticidal compounds of the formula ##STR1## wherein the various substituents are defined hereinbelow. |
| US-4,833,158 |
Method of combating termites This invention provides a method of combating termites at a locus, which comprises treating the locus e.g. soil or timber with an acyl urea of the formula ... |
| US-4,833,157 |
Methods of inhibitng gastric secretion with prostaglandin derivatives A therapeutic method for inhibiting gastric secretion in an individual for whom such therapy is indicated is disclosed. The method comprises administering to... |
| US-4,833,156 |
Treating amnesia with a pyrrolidone derivative A use of the pyrrolidone derivative represented by the following formula [I] as an anti-amnesitc agent: ##STR1## wherein R represents a group ##STR2## ... |
| US-4,833,155 |
3-(.omega.-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and
anti-inflammatory uses thereof 3-[.omega.-(3,5-Di-t-butyl-4-hydroxyphenyl)alkanoyl]-pyrroles and their de-oxy analogs, for example, 3-(3,5-di-t-butyl-4-hydroxybenzyl)pyrrole, ... |
| US-4,833,154 |
Natural sleeping pill to prevent and alleviate insomnia A natural sleeping pill for preventing and alleviating insomnia, designed specifically for people who enjoy absolutely no benefit from other conventional drugs... |
| US-4,833,153 |
Indole derivatives Compounds are disclosed of formula (I): ##STR1## wherein one of R.sup.1, R.sup.2 and R.sup.3 represents hydrogen, C.sub.1-6 alkyl C.sub.3-6 alkenyl,... |
| US-4,833,152 |
Anti-hypertensive agents Novel inhibitors of angiotensin coverting enzyme having the general formula R - A - S - Z are disclosed as potent inhibitors of angiotensin converting enzyme and... |
| US-4,833,151 |
Insecticidal Ureas and thioureas Certain organic compounds derived from urea or thio-urea having insectical activity and methods of their preparation are disclosed. The compounds according to... |
| US-4,833,150 |
1,4-dihydropyridines Compounds having calcium channel antagonist activity of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are each independently amino, trifluoromethyl, ... |
| US-4,833,149 |
2- or 3-aryl substituted imidazo[1,2-a]pyridines Novel 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their synthesis are described. The compounds have local anesthetic properties and are useful as local... |
| US-4,833,148 |
Method of using alkenyl- or alkynyl-substituted thiobarbiturates to
reduce neurotoxic injury Methods and compositions are described for treatment to control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or... |
| US-4,833,147 |
Sebosuppressive compositions and method for suppressing sebaceous gland
activity Sebosuppressive compositions comprising a cosmetically- and pharmaceutically-acceptable carrier and an antiseborrheic agent consisting essentially of a 4-alkoxy-... |
| US-4,833,146 |
Tertiary hydroxyalkylxanthines, medicaments containing them and their use Tertiary hydroxyalkylxanthines having the general formula (I), characterized by the fact that at least one of the residues R.sup.1 and R.sup.3 represents a... |
| US-4,833,145 |
4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives Derivatives of N-[4-(N-[2-amino-4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-ylme thyl]-amino)benzoyl]-L-glutamic acid are antineoplastic agents. Their ... |
| US-4,833,144 |
2-Alkylsulfinyl-4(3H)-quinazolinone derivatives and pharmaceutical
compositions 2-Alkylsulfinyl-4(3H)-quinazolinone derivatives of formula (I) are provided. ##STR1## wherein R.sub.1 is a C.sub.1 -C.sub.6 alkyl group, an aryl group, a ... |
| US-4,833,143 |
Antidepressant amines Compounds of formula I ##STR1## in which R.sub.1 is a heterocyclic ring containing one or more heteroatoms selected from N, O and S; in which R.sub.2 is H,... |
| US-4,833,142 |
Blood-pressure lowering 4-bicyclic-1-piperazinyl-alkyl amides Blood-pressure lowering compounds having a structure as shown in the accompanying formula sheets. |
| US-4,833,141 |
4-[4-[[2-(halophenyl)-2-[1H-tr:azol(or
... The invention relates to new 1,4-piperazine compounds corresponding to the following general formula ##STR1## which show improved antimycotic activity in... |
| US-4,833,140 |
1-(benzyl or pyridylmethyl)-4 or 5-aminomethyl-pyrrolidin-2-ones Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or alkyl of 1 to 4 carbon atoms; R.sub.2 is 2-, 3- or 4-pyridyl, phenyl or mono- or disubstituted... |
| US-4,833,139 |
Enhancing cholinergic activity with 5-substituted
1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinones and related... There are disclosed compounds of the formula ##STR1## where R.sub.1 is loweralkoxycarbonyl, --CH.sub.2 OH or --CONR.sub.3 R.sub.4, R.sub.3 and R.sub.4 being... |
| US-4,833,138 |
Phenothiazinealkaneamines for treatment of neurotoxic injury Compounds, compositions and methods of treatment are described to control brain damage associated with anoxia or ischemia which typically follows such conditions... |
| US-4,833,137 |
Benzothiazinone derivatives The invention provides benzothiazinone derivatives of formula ##STR1## wherein R.sub.1 represents a nitrogen-containing heteroaromatic group or a phenyl... |
| US-4,833,136 |
Pharmaceutically useful pyrazolo[4,3-b]pyridines A compound of the formula (I) or a salt or solvate thereof: ##STR1## in which: R.sub.0 is hydrogen or C.sub.1-6 alkyl; or together with R.sub.3 is C.sub.4-6... |
| US-4,833,135 |
Antioestrogenic phenol derivatives A phenol derivative of the formula wherein NU is a defined bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl; hydroxyphenyl-hydroxy-indanyl, ... |
| US-4,833,134 |
Cephem compounds Cephem compounds of the formula: ##STR1## wherein Q stands for a nitrogen atom or CH, R.sup.1 stands for a hydrogen atom or an optionally substituted lower... |
| US-4,833,133 |
Method of regulating fertility in cattle using epostane The method of regulating fertility in cattle which comprises administering to a normally cycling cow in the early luteal phase of the cycle an amount of epostane... |
| US-4,833,132 |
Process for treating a warm-blooded animal with an
antineoplastic/antime-tastatic effective composition There is disclosed a process for treating a warm-blooded animal wherein there is administered to the warm-blooded animal a therapeutically effective amount of... |
| US-4,833,131 |
Soluble phosphorylated glucan: methods and compositions for wound healing A new class of soluble phosphorylated glucans is described as well as the process for making the same. According to one embodiment, the soluble phosphorylated... |
| US-4,833,130 |
Treatment of human viral infections Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound ... |
| US-4,833,129 |
Hypocholesterolemically and/or hypotriglyceridemically active RNA
fractions Hypocholesterolemically and/or hypotriglyceridemically active RNA fractions having the following characteristics: (a) Molecular weight by gel filtration:... |
| US-4,833,128 |
Dietary supplement A dietary supplement formulated to suppress appetite comprising L-phenylalanine in combination with restricted quantities of protein, carbohydrate, fat and... |
| US-4,833,127 |
Novel CSF and method for obtaining the same A novel colony stimulating factor (CSF) that has the ability to promote the differentiation and proliferation of human bone marrow cells to neutrophiles, and a... |
| US-4,833,126 |
Pharmacologically active compounds and use The peptides of the formula ##STR1## together with their pharmacologically acceptable salts, which have been described as exhibiting analgesic,... |
| US-4,833,125 |
Method of increasing bone mass A method for increasing bone mass in a human afflicted with osteoporosis or a similar disease which comprises administering to the human so afflicated an... |